We evaluated tele-ophthalmology for diabetic retinopathy screening in a primary care setting. Four general practitioners (GPs) were taught to assess non-mydriatic retinography images of patients with diabetes. After training, a total of 1223 patients were screened using this method: 926 (76%) did not have diabetic retinopathy and 297 (24%) were referred for an ophthalmologic assessment. Of the 297 patients, 186 (15%) did not have diabetic retinopathy and were considered to be false positives, 85 (7%) had diabetic retinopathy and in 26 cases (2%) the retinography images were unreadable. The specificity of GPs for detecting diabetic retinopathy by non-mydriatic retinography was 83%. Ophthalmologists also assessed 120 patients who had been diagnosed as normal to detect false negatives. Ten patients (8.3%) had mild non-proliferative diabetic retinopathy with small isolated retinal hemorrhages. Only one patient (0.8%) had treatable diabetic retinopathy with hard exudates and microaneurysms. The sensitivity of GPs for detecting diabetic retinopathy was 90.9%; the sensitivity for detecting treatable lesions was 99.2%. We concluded that adequately trained GPs can screen for treatable lesions of diabetic retinopathy with a very high level of reliability using non-mydriatic retinography.
RESUMENCaso clínico: Se describe un brote de Síndrome Tóxico del Segmento Anterior después de cirugía vítrea. Dos pacientes habían sido intervenidos exclusivamente mediante vitrectomía mientras que los otros tres fueron sometidos a vitrectomía y algún otro procedimiento del segmento anterior. Discusión: El Síndrome Tóxico del Segmento Anterior es una inflamación postoperatoria estéril provocada por alguna sustancia no infecciosa que alcanza el polo anterior durante la cirugía. Suele ocurrir en brotes y aunque la mayoría de los casos han sido descritos después de cirugía del segmento anterior, los casos que presentamos demuestran que es posible su aparición tras cirugía vítrea.Palabras clave: Síndrome tóxico segmento anterior, vitrectomía.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.